These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 9886238

  • 1. Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors.
    van de Waterbeemd H, Camenisch G, Folkers G, Chretien JR, Raevsky OA.
    J Drug Target; 1998; 6(2):151-65. PubMed ID: 9886238
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
    Mahar Doan KM, Humphreys JE, Webster LO, Wring SA, Shampine LJ, Serabjit-Singh CJ, Adkison KK, Polli JW.
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1029-37. PubMed ID: 12438524
    [Abstract] [Full Text] [Related]

  • 4. [Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].
    Guo ZR.
    Yao Xue Xue Bao; 2008 Mar; 43(3):227-33. PubMed ID: 18630256
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Factors affecting delivery of antiviral drugs to the brain.
    Strazielle N, Ghersi-Egea JF.
    Rev Med Virol; 2005 Mar; 15(2):105-33. PubMed ID: 15546130
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Analysis of the calculated physicochemical properties of respiratory drugs: can we design for inhaled drugs yet?
    Ritchie TJ, Luscombe CN, Macdonald SJ.
    J Chem Inf Model; 2009 Apr; 49(4):1025-32. PubMed ID: 19275169
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Predicting blood-brain barrier penetration of drugs using an artificial neural network.
    Fu XC, Wang GP, Liang WQ, Yu QS.
    Pharmazie; 2004 Feb; 59(2):126-30. PubMed ID: 15025181
    [Abstract] [Full Text] [Related]

  • 19. Physicochemical considerations and pharmacokinetic behavior in delivery of drugs to the central nervous system.
    Mellett LB.
    Cancer Treat Rep; 1977 Jul; 61(4):527-31. PubMed ID: 884690
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.